Παθολόγος - Λοιμωξιολόγος
Διευθυντής

Τομεάρχης Παθολογικού

Δ’ Παθολογικό Τμήμα

Όροφος: 2ος -  Κτήριο Α’

Τηλέφωνο: 210-6979094

Email: m.falagas@dunant.gr

Επαγγελματική Προϋπηρεσία

  • Διευθυντής Δ΄ Παθολογικού Τμήματος, Ερρίκος Ντυνάν Hospital Center (4/2017 - σήμερα)
  • Adjunct Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts (2006 - σήμερα)
  • Adjunct Assistant Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts (1997 - 2006)
  • Διευθυντής, Άλφα Ινστιτούτο Βιοϊατρικών Επιστημών (ΑΙΒΕ) (επιβλέπων μεγάλου αριθμού εκπαιδευόμενων ερευνητών) (2005 - σήμερα)
  • Διευθυντής Παθολογικής - Λοιμωξιολογικής Κλινικής , Ιασώ General (3/2014 - 3/2017 )
  • Διευθυντής Παθολογικής - Λοιμωξιολογικής Κλινικής, Μητέρα, Όμιλος Υγεία (6/2012 - 2/2014)
  • Διευθυντής Λοιμωξιολογικού Ιατρείου και Διευθυντής Ιατρείου Πρόληψης και Προστασίας Προσωπικού, Νοσοκομείο Ερρίκος Ντυνάν (3/2003 - 5/2012)
  • Επιστημονικός Συνεργάτης, Υγεία (10/1997 - 2/2003)

Εκπαίδευση / Ειδικότητα

  • Clinical and Research Fellow in Infectious Diseases and Geographic Medicine, Department of Medicine, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts (1994 - 1996)
  • Clinical Fellow in Infectious Diseases and Geographic Medicine, Department of Medicine, Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts (1993 - 1994)
  • Senior Resident in Internal Medicine, Tufts University School of Medicine, Newton-Wellesley Hospital, Boston, Massachusetts (1992 - 1993)
  • Intern and Junior Resident in Internal Medicine, State University of New York (SUNY) at Buffalo, School of Medicine and Biomedical Sciences, Buffalo General Hospital, Buffalo, New York (1990 - 1992)
  • Ιατρική Σχολή Αθηνών, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (MD) (1980 - 1986)

Εξειδίκευση στη ΛοιμωξιολογίαΕρευνητικό ενδιαφέρον στην ανάπτυξη νέων θεραπειών για λοιμώξεις

Μετεκπαίδευση

  • MSc, Harvard University, Harvard School of Public Health (Epidemiology) (1994 - 1996)
  • DSc, Ιατρική Σχολή Αθηνών, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (1996 - 1999)
  • Certified Diplomate in Infectious Diseases by the American Board of Internal Medicine (committee of Infectious Diseases) (1996)
  • Certified Diplomate in Internal Medicine by the American Board of Internal Medicine (1993)
  • Άδεια άσκησης ιατρικού επαγγέλματος στη Μασσαχουσσέτη (1992)
  • USA Educational Commission for Foreign Medical Graduates (ECFMG) permanent certificate (1991)
  • Άδεια άσκησης ιατρικού επαγγέλματος στην Ελλάδα (1986)

Διακρίσεις Βραβεία

  • ESCMID Fellow (European Society of Clinical Microbiology and Infectious Diseases Fellow) (2017)
  • Βραβείο για αριστεία στην έρευνα, Ελληνική Εταιρεία Επείγουσας και Εξωνοσοκομειακής Ιατρικής (2016)
  • Distinction for the study “Readability of health related pamphlets distributed in hospitals and health centers in Athens”, 3rd Pan-Hellenic Congress on Health Management, Economics, and Policy (2007)
  • Maxwell Finland Young Investigator Award for Excellence inResearch, Massachusetts Infectious Diseases Society(1997)
  • Research Award (for the study: Cancer incidence after metronidazole use: a matched metronidazole user/non-user study), Amfiaraion Foundation for the Study of Chemotherapeutic Agents, 23rd Panhellenic Medical Conference, Athens, Greece (1997) 
  • Edward Kass Award for Clinical Excellence, Massachusetts Infectious Diseases Society (1994)
  • House Staff Award for Excellence in Teaching, The Medical Student Body State University of New York (SUNY) at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York (1992 )
  • House Staff Award for Excellence in Teaching, The Medical Student Body (1992)
  • Δίπλωμα από την Ιατρική Σχολή Πανεπιστημίου Αθηνών με “Άριστα” (1986) 
  • Υποτροφία στην Ιατρική Σχολή Πανεπιστημίου Αθηνών (1981-1986)
  • Πρώτο Βραβείο στον πανελλήνιο διαγωνισμό στα μαθηματικά από την Ελληνική Μαθηματική Εταιρεία (1980)

Δημοσιεύσεις

1.  Falagas ME, Rafailidis PI. Pseudomonas and related Gram-negative bacillary infections. In: Goldman L, Schafer A (ed). Goldman-Cecil Medicine. 25th edition. Saunders, Elsevier, Philadelphia, Pennsylvania, 2016, pages 1962-1967.

 

2.  Falagas ME, Mylonakis E (editors). Gorbach’s 5-Minute Infectious Diseases Consult (textbook), 2nd edition. Lippincott, Williams &Wilkins, Philadephia, Pensylvania, 2012.

 

3.  Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ, Hellenic Cefiderocol Study Group. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals. J Antimicrob Chemother 2017.

 

4.  Vardakas KZ, Trigkidis KK, Falagas ME. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect 2017;23:234-241.

 

5.  Tansarli GS, Skalidis T, Legakis NJ, Falagas ME. Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study. Eur J Clin Microbiol Infect Dis 2017;36: 227-232.

  

6.  Vardakas KZ, Theocharis G, Tansarli GS, Rafailidis P, Falagas ME. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study. Arch Virol 2016;161:2511-8.

  

7.  Falagas ME, Mavroudis AD, Vardakas KZ. The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect? Expert Rev Anti Infect Ther. 2016;14:747-63.

 

8.  Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767-77.

 

9.  Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME. Maternal influenza vaccination and risk for congenital malformations: A Systematic Review and Meta-analysis. Obstet Gynecol 2015;126:1075-84.

 

10.  Rajenderan S, Balaji V, Anandan S, Sahni RD, Tansarli GS, Falagas ME. Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study. PLoS ONE 2014;9:e103253.

 

11.  Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis 2013;56:272-82.

 

12.  Maraki S, Samonis G, Karageorgopoulos DE, Mavros MN, Kofteridis D, Falagas ME. In vitro antimicrobial susceptibility to isepamicin of 6296 Enterobacteriaceae clinical isolates collected at a tertiary-care University Hospital in Greece. Antimicrob Agents Chemother 2012;56:3067-73.

 

13.  Falagas ME, Karageorgopoulos DE. Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 2010;375:248-51.

 

14.  Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI. Inaccuracies in dosing drugs with teaspoons-tablespoons. Int J Clin Pract 2010;64:1185-9.

 

15.  Falagas ME, Rafailidis PI, Ioannidou E, Alexiou VG, Matthaiou DK, Karageorgopoulos DE, Kapaskelis A, Nikita D, Michalopoulos A. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010;35:194-9.

 

16.  Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for the treatment of acute sinusitis: a meta-analysis of randomized controlled trials. Lancet Infect Dis 2008;8:543-52.

 

17.  Falagas ME, Siempos II, Vardakas KZ. Linezolid versus a glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: a meta-analysis of randomized controlled trials. Lancet Infect Dis 2008;8:53-66.

 

18.  Falagas ME Effect of blinded peer review on abstract acceptance. JAMA 2006;296:1230.

 

19.  Kopterides P, Falagas ME. Potential consequences of the pneumococcal conjugate vaccine. N Engl J Med 2006;355:95.

 

20.  Falagas ME, Vergidis PI. Diseases that masquerade as infectious cellulitis.  Ann Intern Med 2005;142:47-55.

Δείτε στο ίδιο Τμήμα